Stock Events

Stock Events

SanBio Company Limited 

$5.51
14
+$0.00+0%Monday 19:12

Statistics

Day High
6.35
Day Low
6.35
52W High
6.35
52W Low
5.48
Volume
1,000
Avg. Volume
3
Mkt Cap
430.11M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Dec 10Expected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.15
-0.11
-0.07
-0.03
Expected EPS
-0.099481317504
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2021
2022
2023
2024
2025
2026
0Revenue
-11.4MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SNBOY. It's not an investment recommendation.
AnGes
3
4563.TSE
Tesla
2
TSLA
Mitsubishi UFJ Financial Group
2
8306.TSE
JX Advanced Metals
2
5016.TSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap37.49B
Biogen Inc. focuses on the discovery, development, and delivery of therapies for neurological and neurodegenerative diseases, competing directly with SanBio's regenerative solutions for neurological conditions.
Novartis
NVS
Mkt Cap303.67B
Novartis AG operates in the pharmaceuticals sector, including treatments for neurological conditions similar to those targeted by SanBio, making it a direct competitor in the neurology healthcare market.
Pfizer
PFE
Mkt Cap173.95B
Pfizer Inc. is involved in the development and commercialization of medicines and vaccines, including for neurological diseases, competing with SanBio's offerings in the healthcare market.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences, Inc. focuses on the development of medicines in areas of unmet medical need, including neurological conditions, positioning it as a competitor to SanBio.
Merck
MRK
Mkt Cap368.89B
Merck & Co., Inc. provides healthcare solutions, including for neurological diseases, making it a competitor in the same therapeutic area as SanBio.
Rogers
ROG
Mkt Cap2.37B
Roche Holding AG engages in the pharmaceuticals and diagnostics business, including neurology and neurodegenerative diseases, directly competing with SanBio's focus areas.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie Inc. researches and develops pharmaceutical products, including for neurological disorders, competing in the same market as SanBio.
AMGEN
AMGN
Mkt Cap251.94B
Amgen Inc. focuses on areas of high unmet medical need, including neurology, which pits it against SanBio in the competition for treatments in this area.
Lilly(Eli) &
LLY
Mkt Cap1.26T
Eli Lilly and Company is engaged in the discovery, development, and marketing of pharmaceutical products for neurological conditions, directly competing with SanBio.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca PLC operates in the biopharmaceutical industry, focusing on innovative medicines, including for neurological diseases, making it a competitor to SanBio.

About

SanBio Company Limited is dedicated to the creation, production, and sale of regenerative cell therapies, primarily concentrated on disorders of the central nervous system. A central component of their portfolio is SB623, a treatment that has completed Phase 2 clinical trials in both the United States and Japan for traumatic brain injury. Beyond this, their comprehensive research pipeline explores the broader potential of SB623 for conditions such as ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigmentosa, spinal cord injury, Parkinson's disease, and Alzheimer's disease. The company's development efforts also encompass other innovative treatments: SB618 for peripheral nerve damage, SB308 for muscular dystrophy, MSC1 for cancer, and MSC2 for inflammatory diseases and optic neuritis. Founded in 2001, SanBio maintains its corporate headquarters in Tokyo, Japan.
Show More
CEO
Keita Mori
Employees
33
Country
Japan
ISIN
US7995731004

Listings

OTC Link
US
SNBIF
TSE
JP
4592.TSE
OTC Link
US
SNBOY

0 Comments

Share your thoughts

FAQs

What is SanBio Company Limited stock price today?▼
The current price of SNBOY is $5.51 USD — it has increased by +0% in the past 24 hours. Watch SanBio Company Limited stock price performance more closely on the chart.
What is SanBio Company Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange SanBio Company Limited stocks are traded under the ticker SNBOY.
What is SanBio Company Limited market cap?▼
Today SanBio Company Limited has the market capitalization of 430.11M
When is the next SanBio Company Limited earnings date?▼
SanBio Company Limited is going to release the next earnings report on December 10, 2026.
What were SanBio Company Limited earnings last quarter?▼
SNBOY earnings for the last quarter are -0.08 USD per share, whereas the estimation was -0.03 USD resulting in a -155.15% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is SanBio Company Limited revenue for the last year?▼
SanBio Company Limited revenue for the last year amounts to 0 USD.
What is SanBio Company Limited net income for the last year?▼
SNBOY net income for the last year is -11.4M USD.
How many employees does SanBio Company Limited have?▼
As of November 7, 2026, the company has 33 employees.
In which sector is SanBio Company Limited located?▼
SanBio Company Limited operates in the Health & Wellness sector.
When did SanBio Company Limited complete a stock split?▼
SanBio Company Limited has not had any recent stock splits.
Where is SanBio Company Limited headquartered?▼
SanBio Company Limited is headquartered in Tokyo, Japan.